Hot Topics: Health Policy & Insurance
by Susan L. Smith, PhD
On either side of our country’s northern border, outrage is brewing about the rich getting priority access to COVID-19 vaccinations. …
Full Article
by Mark G. Kuczewski, PhD
Another day, another headline to stoke fear in the minds and hearts of immigrants. This one did not come from the federal government but was based on the statements of Governor Pete Ricketts of Nebraska.…
Full Article
by Craig Klugman, Ph.D.
It is hard to know what to write in the middle of another drawn out ballot counting election in the U.S.…
Full Article
by Craig Klugman, Ph.D.
During election years, I usually blog about any health and bioethics-related issues raised during debates between candidates.…
Full Article
by Daniel Du Pont, MD, MBE and Jill Baren, MD, MS, MBA, FACEP, FAAP
The novel coronavirus outbreak, like any pandemic, has brought with it many difficult choices.…
Full Article
by Carlo Alfredo Clerici, MD, Tullio Proserpio, PhD, Costanza Raimondi, PhD candidate
The COVID pandemic has exposed us to our own fragility and has forced the entire world to confront a condition with no cure.…
Full Article
by David Magnus, Ph.D.
The past three months have witnessed this country (and the world) go through the most serious pandemic since 1918; the greatest economic collapse since the great depression; and the murder of George Floyd has set off a protest movement across the country that has arguably not been seen since 1968.
by Craig Klugman, Ph.D.
In 2009, after an outbreak of H1N1 flu, the Institutes of Medicine (IOM) issued a letter that encouraged all states to begin planning for a pandemic flu.…
Full Article
by Keisha Ray, Ph.D.
I take the drug hydroxychloroquine, brand name Plaquenil, for an autoimmune disease. Hydroxychloroquine was once used to treat malaria and is now commonly used to treat a range of inflammatory disorders like lupus and rheumatoid arthritis.…
Full Article
by Laura Guidry-Grimes, PhD and Katie Savin, MSW
The COVID-19 pandemic has led to intense conversations about ventilator allocation and reallocation during a crisis standard of care (CSC).
Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization
Positive Public Health Ethics: Toward Flourishing and Resilient Communities and Individuals
Should Lack of Social Support Prevent Access to Organ Transplantation?
A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest
The Genetic Revolution Highlights the Importance of Nondiscriminatory and Comprehensive Health Insurance Coverage
Why Insurance Companies Should Pay for Medical Cannabis
Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies
Facial Feminization Surgery: The Ethics of Gatekeeping in Transgender Health
“Working with limited supplies and imperfect scheduling systems, many pharmacists are drowning under a flood of inquiries. Wait lists, where they exist, are getting longer. And even creative solutions are succumbing to the cold realities of the day.”
Full ArticleHow is medical ethics debated in court? “If a Texas court ruling is allowed to stand, the state’s hospitals and doctors will have no room to make end-of-life care decisions based on independent medical ethics or individual conscience.”
Full Article“Yet, design choices in the built health care environment raise substantive bioethical issues that demand the attention of bioethicists and ethical inquiry. It is time for the built environment to be considered alongside other parameters of care.”
Full ArticleWith efficacious medications available, ethics considers who has access to these drugs and who is at risk of losing them. Under COVID-19, the pandemic has accelerated the growth of many health disparities in the United States. Recently, there has been an increase in “pharmacy deserts”, where people struggle to fill medications locally because the drugs are no longer covered by Medicare of Medicaid.
Full ArticleMore and more microbes are becoming resistant to antimicrobial drugs, yet why are fewer antibiotics entering the market? For some, there is a lack of financial incentive to develop antibiotics and firms drop out in pursuit of more profitable drug lines.
Full ArticleCan AI help doctors differentiate between COVID-19 and the regular flu? What information would the technology need and where should we draw those boundaries? Some models are showing promise by sifting through common health data.
Full ArticleThe drop, despite a strong economy, was the first since 2009 and at least partly caused by efforts to weaken the Affordable Care Act.
Full ArticleMost hospitals do not frequently take patients to court over medical debt. But since 2015, Carlsbad Medical Center, in New Mexico, has filed lawsuits by the thousands.
Full ArticleA new Colorado law will ensure that those living with diabetes will spend no more than $100 per month on insulin, making it the first state to limit the cost of an increasingly expensive medication millions of Americans rely on.
Full Article